Occupe actuellement un poste chez Pfizer Inc
Position | Company | Period |
---|---|---|
Executive Vice President, General Counsel | Pfizer Inc | 1 février 2014 - |
Executive Vice President, General Counsel, Corporate Secretary | Pfizer Inc | 1 janvier 2014 - 1 février 2014 |
Executive Vice President, General Counsel | Pfizer Inc | 1 décembre 2013 - 1 janvier 2014 |
Executive Vice President, Chief Compliance and Risk Officer | Pfizer Inc | 1 février 2011 - 1 décembre 2013 |
Rechercher
Date de notification | Date de transaction | A/V Type de transaction |
Nb. d'actions Prix Valeur |
Nombre d'actions | Prix | Valeur totale | Détails | |
---|---|---|---|---|---|---|---|---|
2022-05-13 | 2022-05-12 |
Pfizer Inc
(PFE)
|
V Vente |
38 273
-32.7%
49,411 891 069 USD |
38 273 -32.7% | 49,41 | 1 891 069 USD | |
2021-11-30 | 2021-11-26 |
Pfizer Inc
(PFE)
|
V Vente |
6 400
-8.8%
54,30347 520 USD |
6 400 -8.8% | 54,30 | 347 520 USD | |
2021-11-30 | 2021-11-26 |
Pfizer Inc
(PFE)
|
V Vente |
5 856
-7.5%
54,31318 039 USD |
5 856 -7.5% | 54,31 | 318 039 USD | |
2021-11-30 | 2021-11-26 |
Pfizer Inc
(PFE)
|
V Vente |
5 765
-6.8%
54,40313 616 USD |
5 765 -6.8% | 54,40 | 313 616 USD | |
2021-11-30 | 2021-11-26 |
Pfizer Inc
(PFE)
|
V Vente |
5 203
-5.8%
54,17281 847 USD |
5 203 -5.8% | 54,17 | 281 847 USD | |
2021-11-30 | 2021-11-26 |
Pfizer Inc
(PFE)
|
V Vente |
4 500
-4.8%
54,55245 475 USD |
4 500 -4.8% | 54,55 | 245 475 USD | |
2021-11-30 | 2021-11-26 |
Pfizer Inc
(PFE)
|
V Vente |
4 200
-4.3%
54,50228 900 USD |
4 200 -4.3% | 54,50 | 228 900 USD | |
2021-11-30 | 2021-11-26 |
Pfizer Inc
(PFE)
|
V Vente |
2 736
-2.7%
54,39148 811 USD |
2 736 -2.7% | 54,39 | 148 811 USD | |
2021-11-30 | 2021-11-26 |
Pfizer Inc
(PFE)
|
V Vente |
1 677
-1.6%
54,4691 329 USD |
1 677 -1.6% | 54,46 | 91 329 USD | |
2021-11-30 | 2021-11-26 |
Pfizer Inc
(PFE)
|
V Vente |
1 497
-1.4%
54,4781 542 USD |
1 497 -1.4% | 54,47 | 81 542 USD | |
2021-11-30 | 2021-11-26 |
Pfizer Inc
(PFE)
|
V Vente |
1 133
-1.1%
54,2661 477 USD |
1 133 -1.1% | 54,26 | 61 477 USD | |
2021-11-30 | 2021-11-26 |
Pfizer Inc
(PFE)
|
V Vente |
909
-0.9%
54,4549 495 USD |
909 -0.9% | 54,45 | 49 495 USD | |
2021-11-30 | 2021-11-26 |
Pfizer Inc
(PFE)
|
V Vente |
124
-0.1%
54,326 736 USD |
124 -0.1% | 54,32 | 6 736 USD | |
2020-05-01 | 2020-04-29 |
Pfizer Inc
(PFE)
|
V Vente |
57 099
-42.2%
37,832 160 055 USD |
57 099 -42.2% | 37,83 | 2 160 055 USD | |
2020-05-01 | 2020-04-29 |
Pfizer Inc
(PFE)
|
V Vente |
7 901
-5.5%
38,01300 317 USD |
7 901 -5.5% | 38,01 | 300 317 USD | |
2019-02-01 | 2019-02-01 |
Pfizer Inc
(PFE)
|
V Vente |
5 000
-11.1%
42,75213 750 USD |
5 000 -11.1% | 42,75 | 213 750 USD | |
2019-02-01 | 2019-01-30 |
Pfizer Inc
(PFE)
|
V Vente |
17 099
-27.5%
41,19704 308 USD |
17 099 -27.5% | 41,19 | 704 308 USD | |
2019-02-01 | 2019-01-30 |
Pfizer Inc
(PFE)
|
V Vente |
9 136
-12.8%
41,20376 403 USD |
9 136 -12.8% | 41,20 | 376 403 USD | |
2019-02-01 | 2019-01-30 |
Pfizer Inc
(PFE)
|
V Vente |
6 000
-7.8%
41,18247 080 USD |
6 000 -7.8% | 41,18 | 247 080 USD | |
2019-02-01 | 2019-01-30 |
Pfizer Inc
(PFE)
|
V Vente |
2 100
-2.6%
41,1686 436 USD |
2 100 -2.6% | 41,16 | 86 436 USD | |
2019-02-01 | 2019-01-30 |
Pfizer Inc
(PFE)
|
V Vente |
1 800
-2.2%
41,1574 070 USD |
1 800 -2.2% | 41,15 | 74 070 USD | |
2019-02-01 | 2019-01-30 |
Pfizer Inc
(PFE)
|
V Vente |
1 500
-1.8%
41,1761 755 USD |
1 500 -1.8% | 41,17 | 61 755 USD | |
2019-02-01 | 2019-01-30 |
Pfizer Inc
(PFE)
|
V Vente |
900
-1.1%
41,2237 098 USD |
900 -1.1% | 41,22 | 37 098 USD | |
2019-02-01 | 2019-01-30 |
Pfizer Inc
(PFE)
|
V Vente |
265
-0.3%
41,2110 921 USD |
265 -0.3% | 41,21 | 10 921 USD |